Department of Medicine.
Department of Pathology, and.
J Clin Invest. 2021 Feb 1;131(3). doi: 10.1172/JCI136222.
Humans have been infected with Mycobacterium tuberculosis (Mtb) for thousands of years. While tuberculosis (TB), one of the deadliest infectious diseases, is caused by uncontrolled Mtb infection, over 90% of presumed infected individuals remain asymptomatic and contain Mtb in a latent TB infection (LTBI) without ever developing disease, and some may clear the infection. A small number of heavily Mtb-exposed individuals appear to resist developing traditional LTBI. Because Mtb has mechanisms for intracellular survival and immune evasion, successful control involves all of the arms of the immune system. Here, we focus on immune responses to Mtb in humans and nonhuman primates and discuss new concepts and outline major knowledge gaps in our understanding of LTBI, ranging from the earliest events of exposure and infection to success or failure of Mtb control.
人类感染结核分枝杆菌 (Mycobacterium tuberculosis, Mtb) 已有数千年的历史。虽然结核病 (tuberculosis, TB) 是最致命的传染病之一,但它是由 Mtb 失控感染引起的。超过 90%的疑似感染者无症状,并且处于潜伏性结核感染 (latent tuberculosis infection, LTBI) 中,从未发展为疾病,有些个体可能清除了感染。少数大量暴露于 Mtb 的个体似乎能够抵抗发展为传统 LTBI。由于 Mtb 具有细胞内生存和免疫逃逸的机制,因此成功的控制需要免疫系统的所有分支。在这里,我们重点关注人类和非人类灵长类动物对 Mtb 的免疫反应,并讨论 LTBI 理解方面的新概念和主要知识空白,范围从暴露和感染的最初事件到 Mtb 控制的成败。